Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Padmanee Sharma, MD, PhD

Professor of Genitourinary Medical Oncology and Immunology in the Division of Cancer Medicine

Biography

Dr. Sharma is an immunologist and oncologist whose research work is focused on investigating mechanisms and pathways within the immune system that facilitate tumor rejection or elicit resistance to immune checkpoint therapy. She is a Professor in the departments of Genitourinary Medical Oncology and Immunology, Associate VP of Immunobiology and the T.C. and Jeanette D. Hsu Endowed Chair in Cell Biology at The University of Texas MD Anderson Cancer Center. She is also the inaugural Scientific Director for the Immunotherapy Platform and the Director of Scientific Programs for the James P. Allison Institute at MD Anderson Cancer Center.

Dr. Sharma has written and conducted multiple innovative immunotherapy clinical trials, with an emphasis on obtaining patients’ tumor samples for in-depth laboratory studies, including the first neoadjuvant trial with immune checkpoint therapy and first clinical trial with immune checkpoint therapy for patients with bladder cancer. Her studies have identified novel resistance mechanisms to
immune checkpoint therapy, including loss of interferon (IFN) signaling, VISTA⁺ immunosuppressive cells, increased EZH2 expression in T cells, TGFβ signaling in bone metastases, and CD73⁺ myeloid cells in GBM. These data have led to initiation of new research studies focused on developing rational combination immunotherapy strategies for the treatment of cancer patients.

As a result of her outstanding contributions to the field of cancer immunotherapy, Dr. Sharma was selected as a member of the American Society for Clinical Investigation (ASCI) and was awarded the Emil Frei III Award for Excellence in Translational Research in 2016, the Coley Award for Distinguished Research for Tumor Immunology in 2018, the Women in Science with Excellence (WISE) Award in 2020, the Heath Memorial Award in 2021 and the Randall Prize for Excellence in Cancer Research in 2021.

Education & Training

  • 2004: Memorial Sloan-Kettering Cancer Center, New York, NY, Clinical Fellowship, Medical Oncology
  • 2000: New York Hospital, Cornell Medical Center, New York, NY, Clinical Residency, Internal Medicine
  • 1998: Pennsylvania State University, Hershey, PA, MD, Medicine
  • 1998: Pennsylvania State University, Hershey, PA, Ph.D., Immunology
  • 1991: Boston University, Boston, MA, MA, Biotechnology
  • 1990: Boston University, Boston, MA, BA, Biology

Awards & Honors

  • 2021: Heath Memorial Award and Randall Prize for Excellence in Cancer Research
  • 2020: Women in Science with Excellence (WISE) Award
  • 2018: Coley Award for Distinguished Research for Tumor Immunology
  • 2016: Emil Frei III Award for Excellence in Translational Research
  • 2012: MD Anderson Cancer Center Faculty Scholar Award; MD Anderson Women Faculty Programs "Woman Leading the Way"; National Institute of Health R01 Award
  • 2011: Cancer Prevention Research Institute of Texas Award
  • 2010: DOD/CDMRP Idea Development Award
  • 2009: American Cancer Society Mentored Research Scholar Grant
  • 2008: Doris Duke Clinical Scientist Development Award; Melanoma Research Alliance Young Investigator Award; Prostate Cancer Foundation Challenge Award in Immunology
  • 2007: Carl C. Anderson, Sr. & Marie Jo Anderson Charitable Foundation; MD Anderson Cancer Center Bladder Cancer SPORE Development Award; The Gillson Longenbaugh Foundation
  • 2006: American Society of Clinical Oncology Career Development Award; Cancer Research Institute Clinical Investigator Award; Prostate Cancer Foundation Young Investigator Award
  • 2005: MD Anderson Cancer Center Institutional Research Grant; MD Anderson Cancer Center Physician Scientist Training Program Award; National Institute of Health Renewal Clinical Loan Repayment Program Award
  • 2003: American Society of Clinical Oncology, Young Investigator Award                 Recipient; Award Recipient, GSK National Medical Oncology Fellows Forum
  • 2002: Award for Abstract Presentation, Doris Duke Symposium
  • 2001: Memorial Sloan-Kettering Cancer Center Institutional NIH T32 Grant
  • 1998: Pennsylvania State University, Department of Medicine Scholarship for    Excellence in Medicine
  • 1995: Pennsylvania State University Student Clinician Research Award
  • 1994: The Judy S. Finkelstein Memorial Award in Immunology
  • 1990: Golden Key National Honor Society